Published ahead of print on August 1, 2002, doi:10.1164/rccm.200205-421OC
Am. J. Respir. Crit. Care Med., Volume 166, Number 8, October 2002, 1099-1104
A more recent version of this article appeared on October 15, 2002
Submitted on May 29, 2002
Accepted on July 25, 2002
PULMONARY FUNCTION TESTS IN PRESCHOOL CHILDREN WITH CYSTIC FIBROSIS
NICOLE BEYDON1*, FRANCIS AMSALLEM2, MIREILLE BELLET3, MICHELE BOULE4, MICHELE CHAUSSAIN5, ANDRE DENJEAN6, REGIS MATRAN7, ISABELLE PIN8, CORINNE ALBERTI9, and CLAUDE GAULTIER1
1 physiology, Robert Debre Hospital, Paris, France,
2 pediatric, Arnaud de Villeneuve Hospital, Montpellier, France,
3 physiology, Morvan Hospital, Brest, France,
4 physiology, Trousseau, Paris, France,
5 physiology, Saint Vincent de Paul hospital, Paris, France,
6 physiology, Poitiers Hospital, Poitiers, France,
7 physiology, Calmette Hospital, Lille, France,
8 physiology, Grenoble Hospital, Grenoble, France,
9 public health, Robert Debre Hospital, Paris, France
* To whom correspondence should be addressed. E-mail: nicole.beydon{at}rdb.ap-hop-paris.fr.
Pulmonary function tests have rarely been assessed in preschool children with cystic fibrosis. The objective of this multicenter study was to compare pulmonary function in 39 preschool children with cystic fibrosis (height, 90 to 130 cm; 16 homozygous F508) and in 79 healthy controls. Functional residual capacity (helium dilution technique) and expiratory interrupter resistance (interrupter technique) were measured. As compared to controls, cystic fibrosis patients had significantly higher expiratory interrupter resistance expressed as absolute values and as Z-scores (1.05±0.36 vs. 0.80±0.20 KPa.L-1.s, P<0.0001; and 1.31±1.72 vs. 0.19±0.97, P<0.0001) and significantly lower specific expiratory interrupter conductance (1.29±0.34 vs. 1.63±0.43 kPa-1.s-1, P<0.0001). The effect of the bronchodilator salbutamol on expiratory interrupter resistance was not significantly different between cystic fibrosis and control children. Expiratory interrupter resistance Z-scores were significantly higher in cystic fibrosis children exposed to passive smoke (n=8) (P<0.03). Cystic fibrosis children with a history of respiratory symptoms (n=31) had significantly higher functional residual capacity Z-scores (P<0.02) and lower specific expiratory interrupter conductance Z-scores (P<0.04). Genotype did not influence the data. We conclude that expiratory interrupter resistance and functional residual capacity measurements may help to follow-up young cystic fibrosis children unable to perform reproducible forced expiratory maneuvers.
Key words: functional residual capacity, expiratory interrupter resistance, bronchodilator, genotype, passive smoke
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Collaco, L. Vanscoy, L. Bremer, K. McDougal, S. M. Blackman, A. Bowers, K. Naughton, J. Jennings, J. Ellen, and G. R. Cutting
Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis Lung Disease
JAMA,
January 30, 2008;
299(4):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Gangell, F. Horak Jr, H. J. Patterson, P. D. Sly, S. M. Stick, and G. L. Hall
Respiratory impedance in children with cystic fibrosis using forced oscillations in clinic
Eur. Respir. J.,
November 1, 2007;
30(5):
892 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Thamrin, C. L Gangell, K. Udomittipong, M. M H Kusel, H. Patterson, T. Fukushima, A. Schultz, G. L Hall, S. M Stick, and P. D Sly
Assessment of bronchodilator responsiveness in preschool children using forced oscillations
Thorax,
September 1, 2007;
62(9):
814 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Davis, A. S. Brody, M. J. Emond, L. C. Brumback, and M. Rosenfeld
Endpoints for Clinical Trials in Young Children with Cystic Fibrosis
Proceedings of the ATS,
August 1, 2007;
4(4):
418 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. J. Terheggen-Lagro, H. G. M. Arets, J. van der Laag, and C. K. van der Ent
Radiological and functional changes over 3 years in young children with cystic fibrosis
Eur. Respir. J.,
August 1, 2007;
30(2):
279 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, S. D. Davis, E. Lombardi, J. L. Allen, H. G. M. Arets, P. Aurora, H. Bisgaard, G. M. Davis, F. M. Ducharme, H. Eigen, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1304 - 1345.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vilozni, L. Bentur, O. Efrati, T. Minuskin, A. Barak, A. Szeinberg, H. Blau, E. Picard, E. Kerem, Y. Yahav, et al.
Spirometry in Early Childhood in Cystic Fibrosis Patients
Chest,
February 1, 2007;
131(2):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M R Thomas, G F Rafferty, R Blowes, J L Peacock, N Marlow, S Calvert, A Milner, and A Greenough
Plethysmograph and interrupter resistance measurements in prematurely born young children
Arch. Dis. Child. Fetal Neonatal Ed.,
May 1, 2006;
91(3):
F193 - F196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Nielsen, T. Pressler, B. Klug, C. Koch, and H. Bisgaard
Serial Lung Function and Responsiveness in Cystic Fibrosis during Early Childhood
Am. J. Respir. Crit. Care Med.,
June 1, 2004;
169(11):
1209 - 1216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Farrell, Z. Li, M. R. Kosorok, A. Laxova, C. G. Green, J. Collins, H.-C. Lai, M. J. Rock, and M. L. Splaingard
Bronchopulmonary Disease in Children with Cystic Fibrosis after Early or Delayed Diagnosis
Am. J. Respir. Crit. Care Med.,
November 1, 2003;
168(9):
1100 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
918 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beydon, I. Pin, R. Matran, M. Chaussain, M. Boule, B. Alain, M. Bellet, F. Amsallem, C. Alberti, A. Denjean, et al.
Pulmonary Function Tests in Preschool Children with Asthma
Am. J. Respir. Crit. Care Med.,
September 15, 2003;
168(6):
640 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
333 - 344.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|